These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15537270)

  • 1. [Intraamniotic surfactant supply as RDS prevention].
    Lisawa J; Pietrasik D; Zwoliński J; Gierowska-Bogusz B; Lewandowski L; Chazan B
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):255-60. PubMed ID: 15537270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of neonatal respiratory distress syndrome with Alveofact--results of a prospective observational study].
    Wauer RR; Schmalisch G; Rogalski M
    Klin Padiatr; 1996; 208(6):355-65. PubMed ID: 9064378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
    Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
    Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial.
    Bevilacqua G; Chernev T; Parmigiani S; Iarakova N; Gaioni L; Volante E; Gambini L; Bussolati G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():47-54. PubMed ID: 10021717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome].
    Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early selective surfactant treatment--also to very premature infants treated with CPAP?].
    Klamer A; Greisen G
    Ugeskr Laeger; 2001 Dec; 163(50):7053-6. PubMed ID: 11794037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment.
    Illia R; Solana C; Oliveri P; Toblli J; Imaz MU; Häbich D
    J Perinat Med; 2004; 32(4):354-8. PubMed ID: 15346823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
    Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant administration to the human fetus in utero: a new approach to prevention of neonatal respiratory distress syndrome (RDS).
    Cosmi EV; La Torre R; Di Iorio R; Anceschi MM
    J Perinat Med; 1996; 24(2):191-3. PubMed ID: 8773946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antepartum prevention and postnatal therapy of respiratory distress syndrome].
    Schrod L; Albert P; Frauendienst-Egger G; von Stockhausen HB
    Z Geburtshilfe Perinatol; 1993; 197(4):184-7. PubMed ID: 8212769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
    Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
    Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome.
    Yalaz M; Arslanoglu S; Akisu M; Atik T; Ergun O; Kultursay N
    Klin Padiatr; 2004; 216(4):230-5. PubMed ID: 15284947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.
    Parmigiani S; Panza C; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of exogenous surfactant administration in clinical practice. Report of a multi-center Italian Observational Study.
    Bevilacqua G
    Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():421-9. PubMed ID: 11424782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-amniotic instillation of surfactants for the prevention of neonatal respiratory distress syndrome following preterm delivery.
    Agarwal N; Bathwal S; Kriplani A; Deorari A; Bhatla N
    Int J Gynaecol Obstet; 2016 Nov; 135(2):196-199. PubMed ID: 27594379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD; Beharry K; Padilla G; Iriye B
    J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.